Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.920 |
Chemical and physical data | |
Formula | C13H18ClN3O4S2 |
Molar mass | 379.87 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Cyclopenthiazide (trade name Navidrex) is a thiazide diuretic used in the treatment of heart failure and hypertension.
Synthesis
Contraindications
Thiazide diuretics increase the excretion of sodium and potassium ions and decrease the excretion of calcium ions and uric acid so they are contraindicated in patients with hyponatraemia, hypokalaemia, hypercalcaemia and hyperuricaemia. They are also contraindicated in patients with Addison's disease.
See also
Symporter inhibitors | |
---|---|
Na-Cl | |
Na-K-Cl | |
See also: Receptor/signaling modulators |
Diuretics (C03) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (and etacrynic acid) |
| ||||||||
Potassium-sparing (at CD) |
| ||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) | |||||||||
Other | |||||||||
Combination products | |||||||||
|
References
- Whitehead CW, Traverso JJ, Sullivan HR, Marshall FJ (1961). "Diuretics. V. 3,4-Dihydro-1,2,4-benzothiadiazine 1,1-Dioxides". The Journal of Organic Chemistry. 26 (8): 2814–2818. doi:10.1021/jo01066a046.
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |